A March 2023 paper tested ChatGPT's software in clinical toxicology. The authors identified the AI executed well when answering clear-cut medical situation thoughts which were "unlikely to generally be skipped by any practitioner in the sphere".Sam Altman, the CEO of OpenAI, reported through a new AI party hosted by VC organization Sequoia that he